2. Cancer Vaccine Exists, Goes Unused

This article, by James Hamblin who is a senior editor at The Atlantic, talks about the existing HPV vaccination that is said to prevent multiple types of cancers before they develop. The vaccination has been out for quite a while and is known to work well but is still put aside and not well recommended by doctors or other medical authorities. The vaccination helps prevent and lower the risk of head, neck and pelvic cancer in both men and women. If this vaccination were to be given to children between the ages of 11 to 12 years old (when the human body produces the strongest antibodies) millions of lives would be saved from the unforgiving death that we all fear and know as cancer. But many still do not receive the vaccination because of its already low popularity in modern medicine, the process of fainting after the vaccination, and or because of its significant price. Whatever the real reason may be, CDC officials are doing the best right now to inform the people, send out recommendations, and keep on researching more and more about the HPV vaccination.

In this article, James Hamblin writes in a demonstrative and strictly informative style with no personal anecdotes or personal pronouns. His main goal was to inform people of the existing vaccination for various cancers and successfully delivers it. He uses informative language giving factual numbers like the percentages of people receiving vaccinations and probability of people that could have been cured by the vaccination. Although the article is just informative, the reader can tell that Hamblin is in favor of the HPV vaccination as he states more pros than cons about the vaccination. Hamblin delivers his message to inform in a news cast-like, professional way by using updated facts, presenting both the pros and cons, and by quoting health officials. He ends the article with a quote that makes up for the cons he stated before. He quotes Dr. Anne Schuchat as she cleverly states "The results we are reporting today are disappointing," Schuchat said. "We don't really have a big news story on teen vaccination results today. But no news is bad news for cancer prevention." This makes up for the cons that were stated earlier because in all truth, there is no bad news for cancer prevention and this leaves the reader with a positive look on the vaccination. Knowing this Hamblin ending his article with this quote.

http://www.theatlantic.com/health/archive/2014/07/theres-a-vaccine-that-can-prevent-cancer-most-people-arent-getting-it/375027/